Experts emphasize the necessity for new biologics to outshine existing therapies to justify their cost, fostering innovation in the IBD market's evolution.
Experts emphasize the necessity for new biologics to outshine existing therapies to justify their cost, fostering innovation in the IBD market's evolution.
